| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 05/18/2006 | WO2006051826A1 Nitrogenous heterocyclic compound and pharmaceutical use thereof |
| 05/18/2006 | WO2006012504A3 Compounds and methods for treatment of thrombosis |
| 05/18/2006 | US20060106220 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 05/18/2006 | US20060106110 Modified amino acid is N-(-5-chlorosalicyloyl)-8-aminocaprylic acid; active agents are heparin, insulin, parathyroid hormone, calcitonin; cardiovascular disorders |
| 05/18/2006 | US20060106059 Melanocortin receptor ligands |
| 05/18/2006 | US20060106050 Thrombin receptor antagonists |
| 05/18/2006 | US20060105987 Sulfur-containing phospholipid derivatives |
| 05/18/2006 | US20060105959 Organic compounds with biological action as thrombin inhibitors and use thereof |
| 05/18/2006 | US20060105957 Loop peptide and TGFalpha for stimulating stem cell proliferation and migration |
| 05/17/2006 | EP1657252A2 PGC-1, a novel brown fat PPAR gamma coactivator |
| 05/17/2006 | EP1656950A1 Immunotoxins directed against CD33 related surface antigens |
| 05/17/2006 | EP1656936A1 Macrophage activation inhibitor |
| 05/17/2006 | EP1656368A2 Substituted hertocyclic derivatives useful as antidiabetic and antiobesity agents and method |
| 05/17/2006 | EP1413174A4 Mounting arrangement for auxiliary burner or lance |
| 05/17/2006 | EP1280555B1 Pharmaceutical composition comprising furosemide and conivaptan for the treatment of congestive heart failure |
| 05/17/2006 | EP1276463A4 Hemostatic agent, method and carrier for applying a blood clotting agent |
| 05/17/2006 | EP1274711B1 New aza-indolyl derivatives |
| 05/17/2006 | EP1214409B1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 05/17/2006 | EP1140881B1 Antithrombotic amides |
| 05/17/2006 | EP1114035B1 Quinazoline derivatives and pharmaceutical applications thereof |
| 05/17/2006 | CN1774281A Pharmaceutical composition comprising proteins and/or polypeptides and colloidal particles |
| 05/17/2006 | CN1772897A Cell factor with several functions |
| 05/17/2006 | CN1772751A Substituted oxazolidinones and their use in the field of blood coagulation |
| 05/17/2006 | CN1772289A Expanding diuretic for treating pulmonary edema in perioperative period of hepatic and biliary diseases |
| 05/17/2006 | CN1772286A Vital energy benefiting and blood nourishing medicine composition |
| 05/17/2006 | CN1772283A Chinese herbal medicine decoction for treating vital energy stagnation and blood stasis type intrauterine device setting hemorrhage and its prepn |
| 05/17/2006 | CN1772278A Chinese herbal medicine decoction for treating vital energy stagnation and blood stasis type vaginal hemorrhage after induced abortion and its prepn |
| 05/17/2006 | CN1772244A Chinese herbal medicine decoction for treating kidney-Qi deficiency type vaginal hemorrhage after induced abortion and its prepn |
| 05/17/2006 | CN1772233A Chinese herbal medicine decoction for treating lower warmer wetness-heat type intrauterine device setting hemorrhage and its prepn |
| 05/17/2006 | CN1772229A Chinese herbal medicine decoction for treating virulent heat-evil type thrombotic angeitis and its prepn |
| 05/17/2006 | CN1772171A Chinese herbal medicine decoction for treating wetness-heat blocking vaginal hemorrhage after induced abortion and its prepn |
| 05/17/2006 | CN1772165A Infantile hematogenous granule and its prepn |
| 05/17/2006 | CN1772104A Chinese herbal medicine decoction for treating blood-heat liver energy stagnation type intrauterine device setting hemorrhage and its prepn |
| 05/17/2006 | CN1772101A Chinese herbal medicine decoction for treating Qi and blood deficiency type vaginal hemorrhage after induced abortion and its prepn |
| 05/17/2006 | CN1772083A Chinese herbal medicine decoction for treating spleen-Qi deficiency type intrauterine device setting hemorrhage and its prepn |
| 05/17/2006 | CN1772041A Quality detection method for compound prepn of red sage and notoginseng |
| 05/17/2006 | CN1772020A Freeze dried pubescent holly powder for injection and its prepn |
| 05/17/2006 | CN1771994A Enteric ass-hide gelatin prepn and its prepn process |
| 05/17/2006 | CN1771987A Sodium diester alginate dripping pill and its prepn |
| 05/17/2006 | CN1771978A Notoginseng triol-saponin composition and its prepn and use |
| 05/17/2006 | CN1771953A Medicine containing cepharanthine |
| 05/17/2006 | CN1771945A Disperese torasemide tablet and its prepn and application |
| 05/17/2006 | CN1771933A Frusemide dripping pill and its prepn |
| 05/17/2006 | CN1256334C Alkoxycarbonylamino benzoic acid or alkoxycarbonylamino tetrazolyl phenyl derilatives as IP antagonists |
| 05/17/2006 | CN1256324C Pyrrolidine derivatives as factor Xa inhibitors |
| 05/17/2006 | CN1256139C Chinese medicinal preparation for lowering viscosity and preventing embolism |
| 05/17/2006 | CN1256124C Blood-supplementing medicine composition and its preparing method |
| 05/17/2006 | CN1256110C Chinese medicine for expelling stasis |
| 05/17/2006 | CN1256108C Ass-hide glue phosphotipid composition and its preparing method |
| 05/17/2006 | CN1256105C Oral liquid medicine from ferments of armilarilla tabescens |
| 05/17/2006 | CN1256083C Medicine for boosting qi and nourishing blood, its prepatation method and application |
| 05/16/2006 | US7045660 [di(ether or thioether)heteroaryl or fluoro substituted aryl] compound or an N-oxide thereof or a salt thereof, useful for inhibiting the production or physiological effects of TNF in treatment of a patient suffering from a disease state associated with a detrimental excess of tumor necrosis factor |
| 05/16/2006 | US7045631 Substituted 2-thio-3, 5-dicyano-4-phenyl-6-aminopyridines and their use as adenosine receptor-selective ligands |
| 05/16/2006 | US7045601 Complexing with metal compound and complexing agent |
| 05/16/2006 | US7045541 Compounds for the treatment of metabolic disorders |
| 05/16/2006 | US7045533 Such as naphthalen-1-yl-(4-pentyloxy-naphthalen-1-yl)-mehtane for treatment/prevention of diseases/conditions associated with cannobinoid receptor activation such as chronic pain, osteo- and rheumatoid arthritis, teno-synovitis and gout |
| 05/16/2006 | US7045526 Substituted 4-amino-2-aryl-tetrahydroquinazolines, their preparation, their use and pharmaceutical preparations comprising them |
| 05/16/2006 | US7045520 Opioid receptor active compounds |
| 05/16/2006 | US7045509 Proteins and nucleic acids encoding same |
| 05/16/2006 | US7045505 Isolation nucleic acids; genetic engineering; diagnosis, therapy, prevention hematopoietic, nervous system disorders |
| 05/16/2006 | US7045500 Comprises peptide with heparin and/or lipopolysaccharide binding activity for use as treatment of endotoxic shock and endometriosis, anticoagulant, angiogenesis inhibitor, antiproliferative agent and contraceptive |
| 05/16/2006 | US7045499 Therapeutic agent |
| 05/16/2006 | US7045353 Determining preferential gene expression pattern in embryonic cells; obtain cells, monitor gene expresion products, incubate with animal growth regulators, monitor gene expresion pattern and differentiation in cells |
| 05/16/2006 | US7045337 Translation system for use in the generation of protein containing adjusted amino acid sequences |
| 05/16/2006 | US7045302 Expressed ligand-vascular intercellular signaling molecule |
| 05/16/2006 | US7045152 Pulmonary disorders in which the S-nitrosoglutathione(GSNO) pool or glutathione pool in the lung is depleted and where reactive oxygen species in lung are increased, are treated by delivering into the lung an agent causing repletion of GSNO |
| 05/16/2006 | US7045148 Recovering embryonic-like stem cells from a placenta; obtain placenta, drain cord blood, flush placenta with anticoagulant solution, recover cells |
| 05/16/2006 | US7045140 Therapeutic delivery of carbon monoxide |
| 05/16/2006 | CA2527154A1 Blood-viscosity reducing agent |
| 05/11/2006 | WO2006049215A1 Combination drug for treating autoimmune disease |
| 05/11/2006 | WO2005011645A8 Selected betaines and their uses |
| 05/11/2006 | WO2002094997A3 Transcriptional regulation of target genes |
| 05/11/2006 | US20060100240 Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| 05/11/2006 | US20060100166 Compounds for modulating the activity of exchange proteins directly activated by camp (epacs) |
| 05/11/2006 | US20060100159 Preventing desensitization of receptors |
| 05/11/2006 | US20060100150 Pharmacokinetic and pharmacodynamic modeling of erythropoietin administration |
| 05/11/2006 | US20060099185 Drug delivery; sustained, high-level expression of a delivered nucleotide sequence encoding erythropoietin, and for in vivo secretion thereof from transduced muscle cells such that systemic delivery |
| 05/11/2006 | CA2589808A1 Combination drug for treating autoimmune disease |
| 05/11/2006 | CA2585615A1 Dicarboxamide derivatives and their use as factor xa inhibitors |
| 05/10/2006 | EP1655296A1 Thrombin inhibitors |
| 05/10/2006 | EP1655291A1 Compounds having thrombopoietin receptor agonism |
| 05/10/2006 | EP1655280A1 Dicarboxylic acid derivates with pharmaceutical properties |
| 05/10/2006 | EP1655028A2 Use of cyclic bioisosteres of purine system derivatives for the treatment of diseases caused by disorders of nitrergic and dopaminergic systems |
| 05/10/2006 | EP1432991A4 Identification and isolation of somatic stem cells and uses thereof |
| 05/10/2006 | EP1370553B1 Rho-kinase inhibitors |
| 05/10/2006 | EP1254159B1 Process for the preparation of acetyl-amidiniophenylalanyl-cyclohexylglycyl-pyridylalaninamides |
| 05/10/2006 | EP0873049B1 Methods for enhanced virus-mediated dna transfer using molecules with virus- and cell-binding domains |
| 05/10/2006 | CN1771249A Pyrazolidine-1,2-dicarboxyldiphenylamide derivatives as coagulation factor xa inhibitors for the treatment of thromboses. |
| 05/10/2006 | CN1771037A Pharmaceutical compositions comprising thieno[2,3-c]pyridine derivatives and use thereof |
| 05/10/2006 | CN1769274A Pyrazinone protease inhibitors |
| 05/10/2006 | CN1768858A Composition and method for repairing nerve damage and enhancing functional recovery of nerve |
| 05/10/2006 | CN1768795A Hawthorn fruit physiological activity |
| 05/10/2006 | CN1768777A Compound formulation of astragalus root for treating cardiovascular and cerebrovascular diseases, its preparing process and application |
| 05/10/2006 | CN1768762A Novel drug administering route of pantocrine injection, its preparation process and novel indications |
| 05/10/2006 | CN1768753A Medicinal composition containing bilobalide B and its preparation process and usage |
| 05/10/2006 | CN1255403C Beta-carboline derivatives useful as inhibitors of phosphodiesterase |
| 05/10/2006 | CN1255145C Chinese medicine preparation for treating kidney swelling and ascites of broiler |
| 05/10/2006 | CN1255100C Soft capsule preparation of Tibet medicine 'unique taste' and preparation method thereof |
| 05/10/2006 | CN1255049C Functional agent for decomposing nicotine and method of preparing the same |
| 05/09/2006 | US7041794 Nucleotide sequence comprises at least one new SNP (single nucleotide polymorphism) |